Results from longevity peptides often develop gradually and subtly over time

Reported adverse events primarily reflect dose-dependent or infusion-related effects and include: Mild to moderate gastrointestinal , including diarrhea, nausea, heartburn, abdominal discomfort.3,57,1718 Odiferous urine , a benign and transient observation.17 Headache, dizziness, or fatigue 3,67,18 Cutaneous reactions , including rash, pruritus, or urticaria.3,67,1718 Transient hypoglycemic episodes , most commonly reported in individuals with diabetes.7,18 Hepatic effects , including transient elevations in liver enzymes in clinical studies and, at excessively high doses in nonclinical studies, evidence of acute hepatic injury.4 Systemic allergic reactions , including rare reports of anaphylaxis.6,1718 Cardiovascular symptoms , such as palpitations, tachycardia, and, very rarely, arrhythmias.56,10,18 Insulin autoimmune syndrome , a rare immune-mediated hypoglycemia.1617 Reported adverse events should be interpreted within the context of study design, population, dose, and duration, and should prompt evaluation of dosing, infusion rate, and concomitant medications as appropriate

Review the published analytical data and third-party test results for each compound in our COA Library, or browse all research peptides
Studies supported by the Virginia Cattle Industry Board are examining whether glutathione can help beef cattle cope with stress caused by grazing on fungus-infected fescue, particularly during periods of summer heat
In: New Aspects in Analyzing the Synaptic Organization of the Brain